MRC1 and colorectal cancer: In some cell lines, the particular signature(s) present in the stock converted to different defective MMR signature(s) during in vitro culture (e.g., acute lymphocytic leukemia MOLT-4) or remained roughly stable (e.g., colorectal cancer CW-2) (Figure 3; Table S3).